Heparin
Active ingredient · 3 therapeutic classes
- Drug class
- Heparin Group
- Availability
- Prescription only
- Routes
- Subcutaneous, Intravenous
- Markets covered
- 3
- Products on record
- 35
Overview
Heparin is an active pharmaceutical ingredient in the Heparin Group group (B01AB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 22 | May 22, 2026 |
| CA Canada | Health Canada | 9 | May 22, 2026 |
| US United States | FDA | 4 | May 12, 2026 |
GBUnited Kingdom· MHRA
22 products
Uses
Treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris and acute peripheral arterial occlusion. In extracorporeal circulation and haemodialysis.
How to take
CACanada· Health Canada
9 products
Uses
9% SODIUM CHLORIDE INJECTION is indicated for anticoagulant therapy: in extracorporeal circulation, in dialysis procedures, as an aid in the maintenance of catheter patency. 1 Pediatrics (< 12 years of age): Safety and effectiveness in pediatric patients have not been established.
2 Geriatrics (> 60 years of age): A higher incidence of bleeding has been reported in patients over 60 years of age, especially women. Clinical studies indicate that lower doses of heparin may be indicated in these patients (see 10 CLINICAL PHARMACOLOGY ).
How to take
USUnited States· FDA
4 products
Uses
1 INDICATIONS AND USAGE Heparin Sodium Injection is indicated for: Prophylaxis and treatment of venous thrombosis and pulmonary embolism; Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; Atrial fibrillation with embolization; Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and cardiac surgery; Prophylaxis and treatment of peripheral arterial embolism.
Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. HEPARIN SODIUM INJECTION is an anticoagulant indicated for ( 1 ) Prophylaxis and treatment of venous thrombosis and pulmonary embolism Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease Atrial fibrillation with embolization Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation) Prevention of clotting in arterial and cardiac surgery Prophylaxis and treatment of peripheral arterial embolism Use as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures
Drug interactions
Known interactions involving Heparin. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 575. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL440950041 · revised June 20, 2025
- [2]Health Canada (DPD) · 00828750 · revised March 22, 2025
- [3]FDA DailyMed · 02fb700d-a28c-4d… · revised September 26, 2025 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.